|
Q3 FY2019
As of Dec 31, 2018
|
Q2 FY2019
As of Sep 30, 2018
|
Q1 FY2019
As of Jun 30, 2018
|
Q4 FY2018
As of Mar 31, 2018
|
Q3 FY2018
As of Dec 31, 2017
|
Q2 FY2018
As of Sep 30, 2017
|
Q1 FY2018
As of Jun 30, 2017
|
Q4 FY2017
As of Mar 31, 2017
|
Q3 FY2017
As of Dec 31, 2016
|
Q2 FY2017
As of Sep 30, 2016
|
Q1 FY2017
As of Jun 30, 2016
|
Q4 FY2016
As of Mar 31, 2016
|
Q3 FY2016
As of Dec 31, 2015
|
Q2 FY2016
As of Sep 30, 2015
|
Q1 FY2016
As of Jun 30, 2015
|
Q4 FY2015
As of Mar 31, 2015
|
Q3 FY2015
As of Dec 31, 2014
|
Q2 FY2015
As of Sep 30, 2014
|
Q1 FY2015
As of Jun 30, 2014
|
Q4 FY2014
As of Mar 31, 2014
|
|
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current assets | ||||||||||||||||||||
| Cash and cash equivalents | ||||||||||||||||||||
| Accounts receivable, net of allowance for doubtful accounts of $215 and $114 as of March 31, 2018 and March 31, 2017, respectively | ||||||||||||||||||||
| Accounts receivable, net of allowance for doubtful accounts of $129 and $215 as of December 31, 2018 and March 31, 2018, respectively | ||||||||||||||||||||
| Restricted cash | ||||||||||||||||||||
| Prepaid expenses and other current assets | ||||||||||||||||||||
| Total current assets | ||||||||||||||||||||
| Property and equipment, net | ||||||||||||||||||||
| Capitalized software development costs, net | ||||||||||||||||||||
| Goodwill | ||||||||||||||||||||
| Other intangibles, net | ||||||||||||||||||||
| Other assets | ||||||||||||||||||||
| Total assets | ||||||||||||||||||||
| Credit facility | ||||||||||||||||||||
| Current liabilities | ||||||||||||||||||||
| Credit facility | ||||||||||||||||||||
| Accounts payable | ||||||||||||||||||||
| Accrued payroll and related liabilities | ||||||||||||||||||||
| Other accrued liabilities | ||||||||||||||||||||
| Deferred revenue | ||||||||||||||||||||
| Income tax payable | ||||||||||||||||||||
| COFACE loan | ||||||||||||||||||||
| Accrued restructuring | ||||||||||||||||||||
| Total current liabilities | ||||||||||||||||||||
| Long-term deferred revenue | ||||||||||||||||||||
| Convertible note, net of debt discount | ||||||||||||||||||||
| Long-term promissory notes | ||||||||||||||||||||
| Other long-term liabilities | ||||||||||||||||||||
| Deferred tax liability, non-current | ||||||||||||||||||||
| Total liabilities | ||||||||||||||||||||
| Stockholders' equity (deficit): | ||||||||||||||||||||
| Common stock, $0.0001 par value; Authorized: 35,000 shares at December 31, 2018 and March 31, 2018; Issued: 15,382 and 15,050 shares at December 31, 2018 and March 31, 2018, respectively; Outstanding: 15,237 and 14,905 shares at December 31, 2018 and March 31, 2018, respectively | ||||||||||||||||||||
| Total common stock, $0.0001 par value; Authorized: 35,000 shares at December 31, 2018 and March 31, 2018; Issued: 15,382 and 15,050 shares at December 31, 2018 and March 31, 2018, respectively; Outstanding: 15,237 and 14,905 shares at December 31, 2018 and March 31, 2018, respectively | ||||||||||||||||||||
| Additional paid-in capital | ||||||||||||||||||||
| Total additional paid-in capital | ||||||||||||||||||||
| Treasury stock at cost - 145 shares at December 31, 2018 and March 31, 2018 | ||||||||||||||||||||
| Total treasury stock at cost - 145 shares at December 31, 2018 and March 31, 2018 | ||||||||||||||||||||
| Accumulated deficit | ||||||||||||||||||||
| Total accumulated deficit | ||||||||||||||||||||
| Accumulated other comprehensive income | ||||||||||||||||||||
| Stockholders’ equity (deficit) | ||||||||||||||||||||
| Total stockholders’ equity (deficit) | ||||||||||||||||||||
| Non-controlling interest | ||||||||||||||||||||
| Total equity | ||||||||||||||||||||
| Liabilities and stockholders’ equity (deficit) | ||||||||||||||||||||
| Total liabilities and stockholders’ equity (deficit) | ||||||||||||||||||||
Loading...
